Developing improved therapeutic uses for existing molecules
Fully Integrated Specialty Pharmaceutical Company
Medexus Pharma, Inc. is a fully integrated specialty pharmaceutical company based in Chicago, Illinois. Medexus has core capabilities in development, operations and commercialization and is focused on the development and commercialization of treatments for autoimmune diseases, oncology, and other near market opportunities with the potential to impact patients’ lives. By forming new partnerships and leveraging our business development efforts, we have the opportunity to make significant medical advancements that can help patients live better lives.
Medexus Pharma, Inc., founded in 2012, is a wholly owned subsidiary of Medexus Pharmaceuticals, a Canadian-based pharmaceutical company formed in October 2018 through a transformative acquisition involving Pediapharm and Medexus, Inc. By combining Pediapharm’s Canadian pediatric specialty pharmaceutical business with the Canadian diversified specialty pharmaceutical business of Medexus and the U.S. autoimmune specialty pharmaceutical business of Medexus Pharma, the Acquisition creates a leading North American commercial-stage specialty pharmaceutical company strategically positioned for future growth.